(Q59289245)

English

Duration of remission to ICI 182,780 compared to megestrol acetate in tamoxifen resistant breast cancer

No description defined

In more languages

default for all languages

No label defined

No description defined

edit

Statements

instance of

scholarly article

0 references

title

Duration of remission to ICI 182,780 compared to megestrol acetate in tamoxifen resistant breast cancer (English)

0 references

1 reference

1 reference

J.F.R. Robertson

1

0 references

A. Howell

series ordinal

2

0 references

D.J. De Friend

series ordinal

3

0 references

R.W. Blarney

series ordinal

4

0 references

P. Walton

series ordinal

5

0 references

publication date

August 1997

0 references

published in

The Breast

0 references

volume

6

0 references

issue

4

0 references

page(s)

186-189

0 references

cites work

Response to a specific antioestrogen (ICI 182780) in tamoxifen-resistant breast cancer

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0960-9776%2897%2990571-3

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetics, pharmacological and anti-tumour effects of the specific anti-oestrogen ICI 182780 in women with advanced breast cancer

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0960-9776%2897%2990571-3

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Factors predicting the response of patients with advanced breast cancer to endocrine (Megace) therapy

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0960-9776%2897%2990571-3

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Tamoxifen versus aminoglutethimide in advanced breast carcinoma: a randomized cross-over trial

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0960-9776%2897%2990571-3

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessment of response to therapy in advanced breast cancer: a project of the Programme on Clinical Oncology of the International Union Against Cancer, Geneva, Switzerland

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0960-9776%2897%2990571-3

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

The definition of the ‘no change’ category in patients treated with endocrine therapy and chemotherapy for advanced carcinoma of the breast

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0960-9776%2897%2990571-3

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Steroidal pure antioestrogens

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0960-9776%2897%2990571-3

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Novel antioestrogens without partial agonist activity

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0960-9776%2897%2990571-3

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of the effects of a pure steroidal antiestrogen with those of tamoxifen in a model of human breast cancer.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0960-9776%2897%2990571-3

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

New endocrine therapies for breast cancer

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0960-9776%2897%2990571-3

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized clinical trial of megestrol acetate versus tamoxifen in paramenopausal or castrated women with advanced breast cancer

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0960-9776%2897%2990571-3

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Megestrol acetate versus tamoxifen in advanced breast cancer: 5-year analysis--a phase III trial of the Piedmont Oncology Association

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0960-9776%2897%2990571-3

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

DOI

10.1016/S0960-9776(97)90571-3

0 references

(Q59289245)

Duration of remission to ICI 182,780 compared to megestrol acetate in tamoxifen resistant breast cancer

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)